A Study to Evaluate the Safety and Antitumor Activity in Subjects With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Carboplatin
Related studies linked through entity extraction aliases.
A Study of the Addition of Avastin (Bevacizumab) to Carboplatin and Paclitaxel Therapy in Patients With Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097, Paclitaxel, and Carboplatin Before Surgery in Treating Patients With Stage II or Stage III Triple-Negative Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Olaparib in Combination With Carboplatin for Refractory or Recurrent Women s Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemoradiotherapy HNSCC, Randomized Study, Docetaxel,Cisplatin, 5FU,Erbitux.
- Status
- COMPLETED
- Phase
- PHASE3
Carboplatin and Paclitaxel With or Without Cediranib Maleate in Treating Patients With Metastatic or Recurrent Cervical Cancer That Cannot Be Removed by Surgery
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Linifanib (ABT-869) in Combination With Carboplatin/Paclitaxel in Japanese Subjects With Non-Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
- Status
- TERMINATED
- Phase
- PHASE2
Study of Intraperitoneal Carboplatin With IV Paclitaxel and Bevacizumab in Untreated Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Neoadjuvant Chemotherapy IV Carboplatin With Weekly Paclitaxel \Bevacizumab for Primary Ovarian
- Status
- COMPLETED
- Phase
- PHASE1
A Safety and Efficacy Study of Farletuzumab in Participants With Adenocarcinoma of the Lung
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Pharmacokinetics of SAR240550 (BSI-201) Twice Weekly in Patients With Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Residual Hypermethylation in Early Stage Non-Small Cell Lung Cancer (NSCLC) As Part of Adjuvant Therapy and Preventive Strategy
- Status
- COMPLETED
- Phase
- NA
Study Of Abraxane® And Carboplatin As First-Line Treatment For Triple Negative Metastatic Breast Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of Bevacizumab in Combination With Gemcitabine and Carboplatin in Participants With Triple Negative Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Genasense, Carboplatin, Paclitaxel (GCP) Combination in Uveal Melanoma
- Status
- TERMINATED
- Phase
- PHASE2
CS-7017 in Combination With Carboplatin/Paclitaxel in Subjects With Stage IIIb/IV Non-small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1
Temsirolimus, Carboplatin, and Paclitaxel as First-Line Therapy in Treating Patients With Newly Diagnosed Stage III-IV Clear Cell Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer
- Status
- COMPLETED
- Phase
- PHASE3